Proton pump inhibitor in the prevention of upper gastrointestinal mucosal injury associated with dual antiplatelet therapy after coronary artery bypass grafting (DACAB-GI-2): study protocol for a randomized controlled trial
This study aims to compare the efficacy and safety of 12 months and 1 month of pantoprazole treatment in preventing DAPT-related upper gastrointestinal mucosal injury after CABG.Trial registrationClinicalTrials.gov NCT03908593.
Source: Trials - Category: Research Source Type: clinical trials
More News: Aspirin | Bleeding | Cardiology | Cardiovascular | Coronary Artery Bypass Graft | Esophagogastroduodenoscopy | Gastroenterology | Heart | Panendoscopy | Pantoprazole | Proton Pump Inhibitors PPIs | Protonix | Research | Study